Lifecore Biomedical, Inc.

Good morning, and thank you for joining LifeCore's fiscal 2025 first quarter earnings call. During the presentation, all participants will be in a listen-only mode. Now I'd like to turn the call over to Stephanie Diaz, Manager of Investor Relations for LifeCore.

Good morning, and thank you for joining us today to discuss LifeCore Biomedical's first quarter fiscal 2025 earnings results. Holding the call today from LifeCore are Paul Joseph, President and Chief Executive Officer, and Ryan Lake, Chief Financial Officer. Before we begin today, I'd like to remind everyone that certain statements made in the course of this conference call contain forward-looking statements. It is important to note that the forward-looking statements made during this call reflect management's judgment and analysis only as of today, October 4, 2024, and the company's actual results could differ materially from those projected in such forward-looking statements. For a more thorough discussion of the risks and uncertainties associated with any forward-looking statements, please see the disclaimer regarding forward-looking statements that is included in our fiscal 2025 first quarter earnings release, which was furnished to the SEC today on form 8K, as well as our other filings with the Securities and Exchange Commission, including but not limited to the company's form 10Q for Q1 fiscal 2025, which was filed this morning. With that, I'd like to turn the call over to Paul Joseph, Chief Executive Officer.

Thank you, Stephanie. Good morning, everyone, and thank you for joining our fiscal 2025 first quarter update. I joined LifeCore last spring with a commitment to position the company for long-term success. Today, I'm pleased to report that in my first 100 days, LifeCore has streamlined its operations, added talented new leaders, signed multiple new customers, regained compliance with NASDAQ's listing requirements, and successfully raised funds. As a result of these achievements, I am even more confident that our company is now on a path to reaching its business potential and creating great value for our customers, employees, partners, and shareholders. I will provide additional details on business development and operations for the period following an overview of our first quarter fiscal 2025 financial results. For that, I'll turn the call over to Ryan.